Citadel Advisors’s Safeguard Scientifics, Inc. SFE Stock Holding History

Citadel Advisors’s Portfolio SFE Stock Details SFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,900	Closed	-$4.99K	–	15537
2023 Q1	$4.99K	Buy	2,900 +1,400	+93%	+$3.86K	﹤0.01%	13909
2022 Q4	$4.65K	Buy	+1,500	New	+$5.04K	﹤0.01%	14078
2021 Q4	–	Sell	-30,800	Closed	-$274K	–	15070
2021 Q3	$274K	Buy	+30,800	New	+$247K	﹤0.01%	11256
2019 Q4	–	Sell	-13,700	Closed	-$155K	–	9934
2019 Q3	$155K	Sell	13,700 -8,800	-39%	-$105K	﹤0.01%	8285
2019 Q2	$272K	Buy	22,500 +9,500	+73%	+$111K	﹤0.01%	7734
2019 Q1	$141K	Buy	+13,000	New	+$132K	﹤0.01%	8409
2016 Q1	–	Sell	-2,700	Closed	-$39K	–	8236
2015 Q4	$39K	Buy	+2,700	New	+$43.6K	﹤0.01%	7494
2014 Q3	–	Sell	-500	Closed	-$10K	–	8485
2014 Q2	$10K	Sell	500 -2,000	-80%	-$40.2K	﹤0.01%	7583
2014 Q1	$55K	Buy	+2,500	New	+$49.7K	﹤0.01%	6703
2013 Q3	–	Sell	-5,300	Closed	-$85K	–	6909
2013 Q2	$85K	Buy	+5,300	New	+$84.2K	﹤0.01%	5338

Other funds holding SFE

CCM

Contrarian Capital Management Greenwich, Connecticut $357M AUM 18.27% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors's SFE Position: Q2 2023 in Review

Citadel Advisors sold out of Safeguard Scientifics, Inc. (SFE) in Q2 2023, closing a stake of 12,460 shares — an estimated $21.4K sold.

Citadel Advisors first reported a position in SFE in Q2 2013 and held it in 20 quarters. The position peaked at $896K in Q3 2021. 45 funds tracked by Wall St. Rank hold SFE as of Q2 2023.

Citadel Advisors reported no remaining Safeguard Scientifics, Inc. position as of Q2 2023 after selling out during the quarter.
Citadel Advisors sold 12,460 Safeguard Scientifics, Inc. shares in Q2 2023, an estimated $21.4K.
Citadel Advisors first reported a position in Safeguard Scientifics, Inc. in Q2 2013 and held it in 20 quarters.
Citadel Advisors's Safeguard Scientifics, Inc. position peaked at $896K in Q3 2021.
45 funds tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.